Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
TCG Crossover Management, LLC (CIK 1839948) reported $3.50B across 47 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: ABVX ($721.7M, 20.65%), CGON ($248.4M, 7.11%), TNGX ($220.3M, 6.30%), COGT ($190.4M, 5.45%), CNTA ($170.3M, 4.87%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | ABVX | ABIVAX SA AMERICAN DEPOSITARY SHARES | $721.7M | 20.65% | 6.5M | Trimmed |
| 2 | CGON | CG ONCOLOGY INC | $248.4M | 7.11% | 3.7M | Hold |
| 3 | TNGX | TANGO THERAPEUTICS INC | $220.3M | 6.30% | 10.5M | Trimmed |
| 4 | COGT | COGENT BIOSCIENCES INC | $190.4M | 5.45% | 4.9M | Trimmed |
| 5 | CNTA | CENTESSA PHARMACEUTICALS PLC | $170.3M | 4.87% | 4.3M | Hold |
| 6 | DNTH | DIANTHUS THERAPEUTICS INC | $140.7M | 4.03% | 1.7M | Hold |
| 7 | TYRA | TYRA BIOSCIENCES INC | $124.4M | 3.56% | 3.2M | Added |
| 8 | IMVT | IMMUNOVANT INC | $110.7M | 3.17% | 4.5M | Added |
| 9 | BCRX | BIOCRYST PHARMACEUTICALS INC | $104.9M | 3.00% | 11.0M | New |
| 10 | MIRM | MIRUM PHARMACEUTICALS INC | $98.1M | 2.81% | 1.1M | Added |
| 11 | VOR | VOR BIOPHARMA INC | $96.5M | 2.76% | 5.7M | New |
| 12 | SYRE | SPYRE THERAPEUTICS INC | $95.9M | 2.74% | 1.9M | Hold |
| 13 | AMLX | AMYLYX PHARMACEUTICALS INC | $86.8M | 2.48% | 6.2M | Hold |
| 14 | IRON | DISC MEDICINE INC | $85.8M | 2.45% | 1.3M | New |
| 15 | DYN | DYNE THERAPEUTICS INC | $83.7M | 2.39% | 4.6M | Hold |
| 16 | GLUE | MONTE ROSA THERAPEUTICS INC | $76.0M | 2.18% | 4.6M | Hold |
| 17 | SVRA | SAVARA INC | $67.5M | 1.93% | 12.4M | Hold |
| 18 | RVMD | REVOLUTION MEDICINES INC | $56.1M | 1.60% | 576,473 | Added |
| 19 | KOD | KODIAK SCIENCES INC | $55.1M | 1.58% | 1.4M | Hold |
| 20 | LB PHARMACEUTICALS INC | $45.3M | 1.30% | 1.8M | Added | |
| 21 | SRZN | SURROZEN INC | $42.9M | 1.23% | 1.5M | New |
| 22 | RLAY | RELAY THERAPEUTICS INC | $42.5M | 1.22% | 4.3M | Added |
| 23 | ADCT | ADC THERAPEUTICS SA | $42.7M | 1.22% | 11.4M | Hold |
| 24 | FULC | FULCRUM THERAPEUTICS INC | $40.3M | 1.15% | 5.2M | Hold |
| 25 | BHVN | BIOHAVEN LTD | $39.2M | 1.12% | 4.6M | Hold |
Source: SEC Form 13F filings · as of 2026-03-31